Ara
Toplam kayıt 66, listelenen: 11-20
GEMIFLOXACIN-INDUCED ALLERGIC MYOCARDIAL INFARCTION: A CASE REPORT
(Elsevier Science Inc, 2019)
Background: Gemifloxacin given once daily for 5-7 days has been shown to be non-inferior to, or in some instances superior to, comparator agents for the treatment of common lower respiratory tract infections. Gemifloxacin ...
LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY
(Elsevier Ireland Ltd, 2019)
[No abstract available]
Thrombolysis in pulmonary embolism: full-dose, low-dose, or catheter-directed thrombolysis?
(W B Saunders Co-Elsevier Inc, 2016)
Letter to the Editor
Takotsubo (stress) cardiomyopathy in childhood
(Springer, 2020)
Takotsubo cardiomyopathy (TC) is a significant cause of acute heart failure in adults. However, triggering factors, ECG and echocardiographic findings, and prognosis of TC have not been well studied in children. Therefore, ...
Ivabradine in cardiogenic shock: Fact or fiction?
(Mosby-Elsevier, 2015)
Letter to the Editor
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
(Massachusetts Medical Soc, 2016)
Metoprolol vs ivabradine in patients with mitral stenosis
(Elsevier Ireland Ltd, 2016)
[No abstract available]
Risk stratification in intermediate-risk acute pulmonary embolism
(W B Saunders Co-Elsevier Inc, 2016)
Obesity and atrial fibrillation
(Elsevier Ireland Ltd, 2016)
Letter to Editor